Matthew W. Johnson

Clinical Psychology · 2003–2020

A researcher in the Science corpus: 7 papers; trusts 10 researchers and is trusted by 17 researchers here, as inferred from the citation graph.

Subfields

• Clinical Psychology — 44 citations into it; #922 of 8,024 by trust here, #1,420 by citations
• Social Psychology — 20 citations into it; #10,186 of 15,694 by trust here, #7,393 by citations
• Cellular and Molecular Neuroscience — 14 citations into it; #839 of 2,998 by trust here, #1,827 by citations
• Pharmacology — 13 citations into it; #559 of 1,112 by trust here, #468 by citations
• Applied Psychology — 11 citations into it; #3,439 of 3,868 by trust here, #2,369 by citations
• Health — 9 citations into it; #1,346 of 2,035 by trust here, #811 by citations
• Toxicology — 9 citations into it; #45 of 76 by trust here, #53 by citations
• Biological Psychiatry — 6 citations into it

Whom Matthew W. Johnson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Roland R. Griffiths
2. K. Fagerström
3. U. McCann
4. R. McCrae
5. R. Jesse
6. W. A. Richards
7. R. Piedmont
8. Franz X. Vollenweider
9. Andrew F. Hayes
10. N. Benowitz

Who trusts Matthew W. Johnson overall

1. David E. Nichols
2. Robin L. Carhart-Harris
3. J. Phelps
4. M. Bogenschutz
5. R. Watts
6. David J. Nutt
7. Leor Roseman
8. Katherine A. MacLean
9. Alyssa A. Forcehimes
10. Roland R. Griffiths

Papers from Matthew W. Johnson's perspective

Ordered by how strongly the researchers Matthew W. Johnson trusts endorse each paper. Same corpus, a different order for every researcher.

1. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (Archives of General Psychiatry)
2. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (Journal of Psychopharmacology)
3. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (Frontiers in Human Neuroscience)
4. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
5. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach
6. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. (Health Psychology)
7. Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (Journal of Nervous and Mental Disease)
8. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (Nature Reviews Neuroscience)
9. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (Psychopharmacology)
10. Religious Coping Methods as Predictors of Psychological, Physical and Spiritual Outcomes among Medically Ill Elderly Patients: A Two-year Longitudinal Study (Journal of Health Psychology)

Their papers

• Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (2011) — 818 citations
• Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. (2003) — 607 citations
• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020) — 1,086 citations
• Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016) — 1,850 citations
• Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (2014) — 848 citations
• Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness (2011) — 795 citations
• Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008) — 812 citations